Improving obstetric fistula care in Africa: The case for regenerative medicine
), Tigist W. Leulseged(2),
(1) University College Cork, Cork, Ireland
(2) Medical Research Lounge (MRL), Addis Ababa, Ethiopia
Corresponding Author
Abstract
References
Nations U. Intensifying efforts to end obstetric fistula within
a decade [Internet]. Vol. 11731. 2022. Available from:
https://www.unfpa.org/resources/intensifying-efforts
end-obstetric-fistula-within-decade-report-secretary
general-a77229
Panés J, Bouma G, Ferrante M, Kucharzik T, Nachury M, de
la Portilla de Juan F, Reinisch W, Selvaggi F,
Tschmelitsch J, Brett NR, Ladouceur M, Binek M,
Hantsbarger G, Campbell-Hill S, Karki C and Buskens
C. INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel
in Patients With Perianal Fistulizing Crohn’s Disease
Treated in the ADMIRE-CD Trial. Inflamm Bowel
Dis. 2022;28(11):1737–45.
Panés J, García-Olmo D, Van Assche G, Colombel JF,
Reinisch W, Baumgart DC, Dignass A, Nachury M,
Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la
Portilla F, Goldin E, Richard MP, Leselbaum A,
Danese S and ADMIRE CD Study Group
Collaborators.. Expanded allogeneic adipose-derived
mesenchymal stem cells (Cx601) for complex perianalfistulas in Crohn’s disease: a phase 3 randomised,
double-blind controlled trial. The Lancet.
;388(10051):1281–90.
Guillo L, Gravier Dumonceau R, Vélier M, Serrero M,
Grimaud F, Sabatier F and Magalon J. Efficacy of
mesenchymal stem cell-based therapies in the
treatment of perianal fistulizing Crohn’s disease: a
systematic review and meta-analysis. Stem Cell
Research and Therapy [Internet]. 2025;16(1).
Available from: https://doi.org/10.1186/s13287-025
-y.
Article Metrics
Abstract View
: 339 times
Download : 183 times
Refbacks
- There are currently no refbacks.




